ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

119
Analysis
Health Care • South Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
bullish•SK Innovation
•09 Mar 2025 16:04

Got the BBIG Rebalancing Results: SK Innovation Is the Trade This Week

This post provides insights into the latest BBIG rebalancing results, breaking down the key shifts and highlighting SK Innovation as the top trade...

Logo
798 Views
Share
•03 Feb 2025 05:50

KRX New Deal Index Rebalance Preview: Smaller Deal Than Usual

Indications are for a smaller rebalance than usual as index performance suffers and AUM continues to shrink. There are some constituent changes...

Logo
1.4k Views
Share
•04 Dec 2024 06:00

KRX Short Interest Weekly (Nov 29th):Korea Zinc, JYP, SK Hynix

We analyzed KRX short interest report for the past week and highlighted short interest changes in Korea Zinc, JYP, SK Hynix.

Logo
500 Views
Share
bearish•Kum Yang
•17 Oct 2024 15:42

Connecting the Dots Between Kum Yang’s Rights Offer & Global Index November Review

This post outlines the current screening status of the Global Index November Review for Korean stocks and explores how it could impact Kum Yang's...

Logo
625 Views
Share
•17 Oct 2024 05:50

Korea: Stocks with Potential Passive Flows in November

There could be 1 add and up to 7 deletes from global passive portfolios in Nov. Trackers will need to trade between US$57m to US$230m of the...

Logo
757 Views
Share
x